Company page

Denali Therapeutics Inc.

Denali Therapeutics Inc. is a public biotechnology company based in the United States, focused on developing therapies for neurodegenerative diseases. The company is listed under the ticker DNLI and has a market capitalization of approximately $3.67 billion. Denali aims to advance its innovative drug candidates to improve the lives of patients affected by these challenging conditions.